1. Home
  2. BH vs SPRY Comparison

BH vs SPRY Comparison

Compare BH & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$303.21

Market Cap

971.1M

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.75

Market Cap

823.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BH
SPRY
Founded
1934
2015
Country
United States
United States
Employees
2359
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.1M
823.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BH
SPRY
Price
$303.21
$8.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
58.0K
1.6M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
N/A
$87.40
Revenue Next Year
N/A
$81.64
P/E Ratio
$597.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$230.12
$6.66
52 Week High
$483.60
$18.63

Technical Indicators

Market Signals
Indicator
BH
SPRY
Relative Strength Index (RSI) 47.87 53.70
Support Level $299.54 $8.61
Resistance Level $321.70 $9.46
Average True Range (ATR) 13.06 0.49
MACD 0.75 0.11
Stochastic Oscillator 74.42 53.39

Price Performance

Historical Comparison
BH
SPRY

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, and Oil and Gas Operations. Its restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The company also reports segment information for Maxim. The majority of revenue is derived from the Restaurant Operations Segment.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: